ZYNERBA PHARMACEUTICALS, INC. Operating Lease Right-of-Use Assets
ZYNERBA PHARMACEUTICALS, INC. had Operating Lease Right-of-Use Assets of $219.04 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-08-14
- 2023-06-30: Operating Lease, Right-of-Use Asset $219.04K.
- 2023-03-31: Operating Lease, Right-of-Use Asset $277.83K.
- 2022-12-31: Operating Lease, Right-of-Use Asset $336.21K.
- 2022-09-30: Operating Lease, Right-of-Use Asset $394.20K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-06-30 | $219.04K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $277.83K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $336.21K 10-Q · filed 2023-08-14 |
| 2022-09-30 | $394.20K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $451.80K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $509.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $565.81K 10-K · filed 2023-03-28 |
| 2021-09-30 | $622.24K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $678.28K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $733.93K 10-Q · filed 2021-05-12 |
| 2021-03-01 | $752.39K 10-Q · filed 2023-08-14 |
| 2020-12-31 | $105.20K 10-K · filed 2022-03-01 |
| 2020-09-30 | $166.89K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $227.53K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $287.16K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $345.85K 10-K · filed 2021-03-10 |
| 2019-11-11 | $386.61K 10-K · filed 2021-03-10 |
| 2019-09-30 | $152.17K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $206.25K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $258.79K 10-Q · filed 2019-05-08 |